Radiobiological characterization of two human chemotherapy-resistant intermediate grade non-Hodgkin's lymphoma cell lines

Radiation Oncology Investigations

Volumn 7, Issue 3, 1999, Pages 158-162

  Aref, Amr ^a,b   Mohammad, Razmi ^a   Yudelev, Mark ^a   Choudhuri, Rajani ^a   Strowbridge, Amy ^a   Orton, Colin ^a   Al Katib, Ayad ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Chemosensitivity; Non Hodgkin's lymphoma cell lines; Radiosensitivity; Sublethal damage

Indexed keywords

COBALT 60;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL SURVIVAL; CHEMOSENSITIVITY; HUMAN; HUMAN CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RADIOBIOLOGY; RADIOSENSITIVITY;

CELL SURVIVAL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG RESISTANCE, NEOPLASM; HUMANS; LYMPHOMA, INTERMEDIATE-GRADE; LYMPHOMA, NON-HODGKIN; RADIATION DOSAGE; RADIATION TOLERANCE; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0032993739     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1999)7:3<158::AID-ROI4>3.0.CO;2-B     Document Type: Article

References (11)

1. Aref A, Narayan S, Mohammad R, Yudelev M, Al-Katib A. Chemoresistant intermediate grade non-Hodgkin lymphoma is only moderately radiosensitive: a clinical and laboratory study. Blood 1997;90(Abstract #845):191a.
2. Glick JH, Kim K, Earle J, O'Connell MJ. An ECOG randomized phase III trial of CHOP vs. CHOP + radiotherapy (XRT) for intermediate grade early state non-Hodgkin's lymphoma (NHL). J Clin Oncol Proc ASCO 1995;14:391.
3. Al-Katib AM, Smith MR, Kamanda WS, Pettit GR, Hamdan M, Mohamed AN, Chelladurai B, Mohammad RM. Bryostatin 1 downregulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts. Clin Cancer Res 1998;4:1305-1314.
4. Nishikori M, Hansen H, Jhanwar S, Fried J, Sordillo P, Koziner B, Lloyd K. Clarkson B. Establishment of a near-tetraploid B-cell lymphoma line with duplication of the 8;14 translocation. Cancer Genet Cytogenet 1984;12:39-50.
5. Al-Katib A, Mohammad R, Hamdan M, Mohamed AN, Dan M, Smith MR. Propagation of Waldenstrom's macroglobulinemia cells in vitro and in severe combined immune deficient mice: utility as a preclinical drug screening model. Blood 1993;81:3034-3042.
6. Lichter AS, Tracy D, Lam W-C, Order SE. Total body irradiation in bone marrow transplantation: the influence of fractionation and delay of marrow infusion. Int J Radiat Oncol Biol Phys 1979;6:301-309.
7. 50 and the survival of bone-marrow colony-forming cells in mice: effect of rate of exposure to ionizing radiation. Radiat Res 1972; 51:374-380.
8. Peters LJ, Withers HR, Cundiff JH, Dicke KA. Radio-biological considerations in the use of total-body irradiation for bone-marrow transplantation. Radiobiology 1979;131:243-247.
9. Johansson L, Carlsson J, Nilsson K. Radiosensitivity of human B-lymphocytic lymphomas in vitro. Int J Radiat Oncol Biol Phys 1982;41:411-420.
10. Drewinko B, Humphrey RM, Trujillo JM. The radiation response of a long-term culture of human lymphoid cells. Int J Radiat Oncol Biol Phys 1972;21:361-373.
11. Song CW, Kim TH, Khan FM, Kersey JH, Levitt SH. Radiobiological basis of total body irradiation with different dose rate and fractionation: repair capacity of hemopoietic cells. Int J Radiat Oncol Biol Phys 1981; 7:1695-1701.